Celebrating the International Day of Women and Girls in Science
LifeArc celebrates this year's UN Day for Women and Girls in STEM.
LifeArc celebrates this year's UN Day for Women and Girls in STEM.
LifeArc’s Chief Scientific Officer Dr Dave Powell comments on news that lecanemab has received regulatory and safety approval from the FDA.
We’ve seen some exciting scientific progress, forged new partnerships and launched some new landmark initiatives.
We cautiously welcome the Government's announcement on how their £50m commitment into MND research will be spent.
Results of an international repurposing study show favipiravir could help with COVID-19.
Welcome to Anna Tomlinson, who joins LifeArc as our first Chief Communications Officer.
LifeArc played an important part in the discovery of lecanemab, an experimental drug that has shown some benefits for people with early Alzheimer’s disease.
The findings reveal that seemingly impossible chemical reactions can be driven through a phenomenon called quantum tunnelling.
AbbVie will pay DJS shareholders approximately $255 million in cash at closing for the acquisition of DJS